Consolidated Statement Of Cash Flows

ONO PHARMACEUTICAL CO., LTD. - Filing #7330506

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss)
127,977,000,000 JPY
127,977,000,000 JPY
128,040,000,000 JPY
62,000,000 JPY
190,000,000 JPY
112,723,000,000 JPY
112,723,000,000 JPY
112,913,000,000 JPY
Depreciation and amortization
18,140,000,000 JPY
17,451,000,000 JPY
Impairment losses (reversal of impairment losses)
14,885,000,000 JPY
1,498,000,000 JPY
Decrease (increase) in inventories
-3,420,000,000 JPY
-2,945,000,000 JPY
Increase (decrease) in retirement benefit liability
-22,000,000 JPY
214,000,000 JPY
Other
197,000,000 JPY
2,347,000,000 JPY
Subtotal
164,517,000,000 JPY
163,935,000,000 JPY
Interest received
221,000,000 JPY
53,000,000 JPY
Dividends received
2,445,000,000 JPY
2,334,000,000 JPY
Interest paid
-92,000,000 JPY
-74,000,000 JPY
Income taxes paid
-56,431,000,000 JPY
-6,637,000,000 JPY
Net cash provided by (used in) operating activities
110,660,000,000 JPY
159,610,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-4,020,000,000 JPY
-5,340,000,000 JPY
Proceeds from sale of property, plant and equipment
903,000,000 JPY
6,000,000 JPY
Purchase of intangible assets
-16,809,000,000 JPY
-9,157,000,000 JPY
Other
-1,287,000,000 JPY
-1,037,000,000 JPY
Net cash provided by (used in) investing activities
48,077,000,000 JPY
-100,259,000,000 JPY
Cash flows from financing activities
Purchase of treasury shares
-50,010,000,000 JPY
-1,000,000 JPY
Dividends paid
-37,183,000,000 JPY
-29,742,000,000 JPY
Dividends paid to non-controlling interests
-9,000,000 JPY
-6,000,000 JPY
Net cash provided by (used in) financing activities
-89,848,000,000 JPY
-32,484,000,000 JPY
Net increase (decrease) in cash and cash equivalents
68,889,000,000 JPY
26,868,000,000 JPY
Cash and cash equivalents
166,141,000,000 JPY
96,135,000,000 JPY
69,112,000,000 JPY
Effect of exchange rate changes on cash and cash equivalents
1,116,000,000 JPY
155,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.